These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


586 related items for PubMed ID: 25991653

  • 1. Involvement of Glutamate NMDA Receptors in the Acute, Long-Term, and Conditioned Effects of Amphetamine on Rat 50 kHz Ultrasonic Vocalizations.
    Costa G, Morelli M, Simola N.
    Int J Neuropsychopharmacol; 2015 May 19; 18(11):pyv057. PubMed ID: 25991653
    [Abstract] [Full Text] [Related]

  • 2. Repeated amphetamine administration and long-term effects on 50-kHz ultrasonic vocalizations: possible relevance to the motivational and dopamine-stimulating properties of the drug.
    Simola N, Morelli M.
    Eur Neuropsychopharmacol; 2015 Mar 19; 25(3):343-55. PubMed ID: 25638025
    [Abstract] [Full Text] [Related]

  • 3. Activation of adenosine A₂A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation.
    Simola N, Costa G, Morelli M.
    Psychopharmacology (Berl); 2016 Feb 19; 233(3):507-19. PubMed ID: 26564233
    [Abstract] [Full Text] [Related]

  • 4. Influence of dopamine transmission in the medial prefrontal cortex and dorsal striatum on the emission of 50-kHz ultrasonic vocalizations in rats treated with amphetamine: Effects on drug-stimulated and conditioned calls.
    Costa G, Serra M, Marongiu J, Morelli M, Simola N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar 08; 97():109797. PubMed ID: 31669508
    [Abstract] [Full Text] [Related]

  • 5. Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: implications for the study of the affective properties of drugs of abuse.
    Simola N, Frau L, Plumitallo A, Morelli M.
    Int J Neuropsychopharmacol; 2014 Mar 08; 17(3):429-41. PubMed ID: 24138707
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Divergent Acute and Enduring Changes in 50-kHz Ultrasonic Vocalizations in Rats Repeatedly Treated With Amphetamine and Dopaminergic Antagonists: New Insights on the Role of Dopamine in Calling Behavior.
    Serra M, Costa G, Onaivi E, Simola N.
    Int J Neuropsychopharmacol; 2024 Feb 01; 27(2):. PubMed ID: 38174899
    [Abstract] [Full Text] [Related]

  • 10. Diverging frequency-modulated 50-kHz vocalization, locomotor activity and conditioned place preference effects in rats given repeated amphetamine treatment.
    Taracha E, Kaniuga E, Chrapusta SJ, Maciejak P, Sliwa L, Hamed A, Krząścik P.
    Neuropharmacology; 2014 Aug 01; 83():128-36. PubMed ID: 24769001
    [Abstract] [Full Text] [Related]

  • 11. Effects of dizocilpine [(+)-MK-801] on the expression of associative and non-associative sensitization to D-amphetamine.
    Grönig M, Atalla A, Kuschinsky K.
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb 01; 369(2):228-31. PubMed ID: 14673514
    [Abstract] [Full Text] [Related]

  • 12. Non-parametric analysis of neurochemical effects and Arc expression in amphetamine-induced 50-kHz ultrasonic vocalization.
    Hamed A, Daszczuk P, Kursa MB, Turzyńska D, Sobolewska A, Lehner M, Boguszewski PM, Szyndler J.
    Behav Brain Res; 2016 Oct 01; 312():174-85. PubMed ID: 27288591
    [Abstract] [Full Text] [Related]

  • 13. Individual behavioural predictors of amphetamine-induced emission of 50 kHz vocalization in rats.
    Mulvihill KG, Brudzynski SM.
    Behav Brain Res; 2018 Sep 17; 350():80-86. PubMed ID: 29758247
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Critical involvement of 5-HT2C receptor function in amphetamine-induced 50-kHz ultrasonic vocalizations in rats.
    Wöhr M, Rippberger H, Schwarting RK, van Gaalen MM.
    Psychopharmacology (Berl); 2015 May 17; 232(10):1817-29. PubMed ID: 25417553
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization.
    Tzschentke TM, Schmidt WJ.
    Behav Brain Res; 1997 Mar 17; 84(1-2):99-107. PubMed ID: 9079776
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.